Most recently, a new posttranscriptional regulator of BCAT1 expression was identified in chronic myeloid leukemia (CML), the musashi RNA binding protein 2 (MSI2) [18▪▪]. Here, BCAT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.